TORC - resTORbio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5362.22M
Enterprise Value 3229.42M
Trailing P/E N/A
Forward P/E 1-4.48
PEG Ratio (5 yr expected) 1-0.16
Price/Sales (ttm)N/A
Price/Book (mrq)2.82
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-4.97

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 30.00%
S&P500 52-Week Change 30.90%
52 Week High 316.66
52 Week Low 36.21
50-Day Moving Average 310.16
200-Day Moving Average 38.64

Share Statistics

Avg Vol (3 month) 3166.54k
Avg Vol (10 day) 3119.96k
Shares Outstanding 528.05M
Float 15.79M
% Held by Insiders 138.10%
% Held by Institutions 147.79%
Shares Short (Jul 31, 2019) 43.27M
Short Ratio (Jul 31, 2019) 416.56
Short % of Float (Jul 31, 2019) 433.89%
Short % of Shares Outstanding (Jul 31, 2019) 49.14%
Shares Short (prior month Jun 28, 2019) 42.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-21.78%
Return on Equity (ttm)-35.69%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -46.15M
Net Income Avi to Common (ttm)-43.56M
Diluted EPS (ttm)-1.44
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)132.8M
Total Cash Per Share (mrq)3.67
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.02
Book Value Per Share (mrq)3.54

Cash Flow Statement

Operating Cash Flow (ttm)-44.83M
Levered Free Cash Flow (ttm)-28.82M